Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | 250MG | 0 | ABIRATERONE ACETATE | ABIRATERONE ACETATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-07-10 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2021-04-05 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2022-09-02 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2022-09-02 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 7 |
SUPPL | 4 | Null | 15 |
SUPPL | 5 | Null | 15 |
TE Codes
CDER Filings
MSN
cder:Array
(
[0] => Array
(
[ApplNo] => 210686
[companyName] => MSN
[docInserts] => ["",""]
[products] => [{"drugName":"ABIRATERONE ACETATE","activeIngredients":"ABIRATERONE ACETATE","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/10\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-07-10
)
)